Medindia

X

Paine & Partners, LLC Announces Sale of Byram Healthcare to OPG Groep N.V.

Wednesday, February 20, 2008 General News J E 4
Advertisement
SAN FRANCISCO and NEW YORK, Feb. 19 Paine & Partners, LLC,the San Francisco and New York-based private equity firm, today announced thesale of Byram Healthcare Centers, Inc. ("Byram"), a leading provider ofdisposable medical supplies to patients in their homes, to OPG Groep N.V.("OPG"). Terms of the transaction were not disclosed.

W. Dexter Paine, III, a founding partner of Paine & Partners, said, "Weare pleased to have been part of Byram's growth and success. As one of theleaders in its industry with over one million customers, Byram is well-knownnationally for reliable and accurate service, an expansive product inventory,and a comprehensive billing and reporting system. The sale of Byram to OPGGroep is the culmination of the efforts of many people who made Byram what itis today and we wish the talented executive team and employees of Byram allthe best as they enter the next chapter of their success."

Byram has been majority-owned since 1999 by a fund currently managed by aPaine & Partners' affiliate. The transaction is subject to normal closingconditions and is expected to close within 45 days.

About Paine & Partners

Paine & Partners, LLC provides equity capital for management buyouts,going private transactions, and company expansion and growth programs. Paine &Partners engages exclusively in friendly transactions developed in cooperationwith a company's management, board of directors, and shareholders. Forfurther information see www.painepartners.com.

SOURCE Paine & Partners, LLC
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
United BioSource Scientist Leads Development of Ne...
S
Boehringer Ingelheim Pharmaceuticals, Inc. Receive...